Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Matrixx Initiatives Inc
WARNING LETTER
•Matrixx Initiatives Inc

Matrixx Initiatives Inc – FDA Warning Letter

Record Details

The FDA issued a Warning Letter to Matrixx Initiatives, Inc. after reviewing their website and labeling for "Zicam Cold Remedy RapidMelts with Vitamin C & Echinacea" and "Zicam Cold Remedy RapidMelts with Vitamin C" products. The Agency determined these products are unapproved new drugs, violating sections 301(d) and 505(a) of the Federal Food, Drug, and Cosmetic Act (the Act), as they are intended to reduce cold duration and severity but lack FDA approval. Vitamin C, an active ingredient, is not generally recognized as safe and effective for this use.

Furthermore, the products are misbranded under section 502 of the Act. Specifically, their labels fail to identify vitamin C and echinacea (in the respective product) as active drug ingredients and omit quantity statements, violating section 502(e)(1)(A)(ii) and 21 CFR §§ 201.10, 201.66(c)(2). The products are also falsely labeled as homeopathic under section 502(a) because vitamin C is not a recognized homeopathic ingredient.

Additionally, inspections revealed Matrixx failed to submit certain serious adverse event reports as required by section 760 of the Act. While the firm's corrective action plan for adverse event reporting was acknowledged, a regulatory meeting was recommended for further clarification. Matrixx must respond within 15 business days with corrective actions and documentation, or a timeline for completion, to avoid potential legal action.

Company
Matrixx Initiatives Inc
Product type
Drugs
Office
Department of Health and Human Services
Person
  • Alonza E. Cruse (Director)
View Company Profile

ID · 7b374d6d-0b58-4765-87f6-5dcc50238f3c

Violation Codes10
21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(g)(1)(C)21 U.S.C. 321(g)(1)(D)21 U.S.C. 321(p)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 352(e)(1)(A)(ii)21 CFR 201.1021 CFR 201.66(c)(2)21 U.S.C. 352(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Matrixx Initiatives Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.